Our team has been investigating RIPK1/RIPK3 and its role in necrotic apoptosis for years, and our previous study showed that the RIPK1 antagonist Cpd-71 prevents cisplatin-induced renal insufficiency by reducing necroptosis and inflammation (Wang et al., 2019b). Here, RIPK1 is linked to Renal insufficiency.